Liu Xiaodong, Lui David Tak Wai, Xiong Xi, Li Lanlan, Luk Yan, Wong Chun Ho, Lee Chi Ho, Wong Carlos King Ho, Fung Matrix Man Him, Lang Brian Hung Hin
Division of Endocrine Surgery, Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Division of Endocrinology and Metabolism, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
JAMA Surg. 2025 Aug 27. doi: 10.1001/jamasurg.2025.3081.
Primary hyperparathyroidism (PHPT) is linked to insulin resistance, glucose intolerance, and diabetes. Whether parathyroidectomy is associated with lower risk of diabetes has not been evaluated in a large cohort.
To examine the independent association between parathyroidectomy and the risk of incident diabetes in patients with PHPT.
DESIGN, SETTING, AND PARTICIPANTS: Patients diagnosed with PHPT between January 2006 and December 2023 were identified from a territorywide electronic health database in Hong Kong and classified into surgical and nonsurgical groups based on presence of subsequent parathyroidectomy. They were followed up with from the index date (first diagnosis of PHPT), until the outcome of interest (incident diabetes), death, or end of the study period (December 2023), whichever came first.
Parathyroidectomy vs nonsurgical management.
The primary outcome of this study was incident diabetes. Inverse probability of treatment weighting was used to balance all baseline characteristics. Cox proportional hazards regression was used to evaluate the hazard of incident diabetes associated with parathyroidectomy.
A total of 3135 patients with PHPT were included (596 [19.0%] surgical and 2539 [81.0%] nonsurgical). The mean (SD) age was 67.5 (14.2) years, and 2211 (70.5%) individuals were female. A total of 518 patients in the nonsurgical group developed incident diabetes during a median (IQR) follow-up of 2.2 (0.9-4.3) years, compared to 156 patients in the surgical group during a median (IQR) follow-up of 5.5 (3.3-8.0) years. Parathyroidectomy was associated with lower risk of incident diabetes (hazard ratio [HR], 0.68 [95% CI, 0.65-0.71]; P < .001). Results were consistent across multiple sensitivity analyses. Subgroup analyses revealed more prominent protective associations among younger patients (age ≤65 years vs >65 years: HR, 0.64 [95% CI, 0.60-0.68] vs HR, 0.68 [95% CI, 0.63-0.72]; interaction P < .001) and those with more severe PHPT (parathyroid hormone [PTH] > twice the upper limit of normal vs PTH ≤ twice the upper limit of normal: HR, 0.58 [95% CI, 0.53-0.63] vs HR, 0.73 [95% CI, 0.69-0.77]; calcium > 2.8 vs calcium ≤ 2.8 mmol/L : HR, 0.58 [95%CI, 0.54-0.63] vs HR, 0.69 [95%CI, 0.66-0.73]; interaction P < .001).
In this cohort of patients with PHPT, parathyroidectomy was associated with a lower risk of incident diabetes. The association was more prominent in younger patients and those with more severe PHPT. These results may suggest potential additional metabolic benefits of parathyroidectomy in PHPT.
原发性甲状旁腺功能亢进症(PHPT)与胰岛素抵抗、葡萄糖耐量异常和糖尿病相关。甲状旁腺切除术是否与较低的糖尿病风险相关尚未在大型队列中进行评估。
探讨甲状旁腺切除术与PHPT患者新发糖尿病风险之间的独立关联。
设计、设置和参与者:从香港全地区电子健康数据库中识别出2006年1月至2023年12月期间诊断为PHPT的患者,并根据随后是否进行甲状旁腺切除术分为手术组和非手术组。从索引日期(首次诊断为PHPT)开始对他们进行随访,直至出现感兴趣的结局(新发糖尿病)、死亡或研究期结束(2023年12月),以先发生者为准。
甲状旁腺切除术与非手术治疗。
本研究的主要结局是新发糖尿病。采用治疗权重逆概率法来平衡所有基线特征。使用Cox比例风险回归来评估与甲状旁腺切除术相关的新发糖尿病风险。
共纳入3135例PHPT患者(596例[19.0%]接受手术,2539例[81.0%]未接受手术)。平均(标准差)年龄为67.5(14.2)岁,2211例(70.5%)为女性。在非手术组中,共有518例患者在中位(四分位间距)随访2.2(0.9 - 4.3)年期间发生新发糖尿病,而手术组中156例患者在中位(四分位间距)随访5.5(3.3 - 8.0)年期间发生新发糖尿病。甲状旁腺切除术与较低的新发糖尿病风险相关(风险比[HR],0.68[95%置信区间,0.65 - 0.71];P < 0.001)。多项敏感性分析结果一致。亚组分析显示,在年轻患者(年龄≤65岁与>65岁:HR,0.64[95%置信区间,0.60 -